LILAS Feminine Pain Relief Patch recalled for manufacturing violations
Unexo Life Sciences is voluntarily recalling LILAS Feminine Pain Relief Patch nationwide due to manufacturing practice deviations affecting 363,300 patches.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: Class II recall with no reported illnesses or injuries. The hazard is a manufacturing practice violation rather than a specific product contamination or defect. Voluntary precautionary recalls without reported adverse events are classified as moderate per the severity rubric.
Plain-English summary
Unexo Life Sciences Private Limited is voluntarily recalling LILAS Feminine Pain Relief Patch, Menthol 10%, due to Current Good Manufacturing Practice (cGMP) deviations. The recall affects approximately 363,300 patches distributed nationwide in the United States.
The affected patches are identified by UPC code 7 87099 48212 1 (5 patches per box) or 7 87099 48211 4 (10 patches per box). The product is distributed by Lilas Wellness, Inc., based in Beaverton, Oregon, with the manufacturer located in New Delhi, India.
The manufacturer initiated this recall on October 24, 2024. The FDA classified the recall as Class II on November 22, 2024. The recall was terminated on September 16, 2025, indicating that the issue has been resolved.
The recalled product
- Product
- LILAS Feminine Pain Relief Patch, Menthol 10%, a) 5 patches per box (UPC 7 87099 48212 1) and 10 patches per box (UPC 7 87099 48211 4), Distributed by: Lilas Wellness, Inc., Beaverton, Oregon 97008-7105
- Manufacturer
- Unexo Life Sciences Private Limited
- Category
- Drug — Topical Pain Relief
- Hazard
- manufacturing-defect
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- a) UPC 7 87099 48212 1 b) UPC 7 87099 48211 4
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- ModerateGas-X Simethicone 125 mg softgels recall for incomplete labeling
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27